| Yazdanpanah Y, Fagard C, Descamps D, et al. High Rate of Virologic Suppression with Raltegravir Plus Etravirine and Darunavir/Ritonavir among Treatment-Experienced Patients Infected with Multidrug-Resistant HIV: Results of the ANRS 139 TRIO Trial. [JOURNAL ARTICLE] Clin Infect Dis 2009 Oct 8. Abstract | Full Citation | | Tomillero A, Moral MA Gateways to clinical trials. [Journal Article] Methods Find Exp Clin Pharmacol 2009 Jul-Aug; 31(6):397-417. Abstract | Full Citation | | de Béthune MP Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: a review of the last 20 years (1989-2009). [JOURNAL ARTICLE] Antiviral Res 2009 Sep 22. Abstract | Full Citation | Find Related Articles | | Eraikhuemen N, Thornton AM, Branch E, et al. Combating Non-nucleoside Reverse Transcriptase Inhibitor Resistance with a Focus On Etravirine (Intelence) for HIV-1 Infection. [Journal Article] P T 2008 Aug; 33(8):445-91. Full Citation | | Varghese V, Shahriar R, Rhee SY, et al. Minority Variants Associated with Transmitted and Acquired HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor Resistance: Implications for the Use of Second-Generation Nonnucleoside Reverse Transcriptase Inhibitors. [JOURNAL ARTICLE] J Acquir Immune Defic Syndr 2009 Sep 3. Abstract | Full Citation | Find Related Articles | | Scherrer AU, Hasse B, von Wyl V, et al. Prevalence of etravirine mutations and impact on response to treatment in routine clinical care: the Swiss HIV Cohort Study (SHCS). [JOURNAL ARTICLE] HIV Med 2009 Sep 1. Abstract | Full Citation | | Schöller-Gyüre M, Kakuda TN, Raoof A, et al. Clinical pharmacokinetics and pharmacodynamics of etravirine. [Journal Article] Clin Pharmacokinet 2009; 48(9):561-74. Abstract | Full Citation | | De Clercq E The history of antiretrovirals: key discoveries over the past 25 years. [JOURNAL ARTICLE] Rev Med Virol 2009 Aug 27; 19(5):287-299. Abstract | Full Citation | | Katlama C, Haubrich R, Lalezari J, et al. Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials. [JOURNAL ARTICLE] AIDS 2009 Aug 25. Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Xu H, Quan Y, Brenner BG, et al. HIV-1 recombinant reverse transcriptase enzymes containing the G190A and Y181C resistance mutations remain sensitive to etravirine. [JOURNAL ARTICLE] Antimicrob Agents Chemother 2009 Aug 24. Abstract | Full Citation | Find Related Articles |  |
|
| | Enter www.unboundmedicine.com/medline in your iPhone browser or View our Unbound MEDLINE iPhone demo Advertise on this site.
|